Puma Biotechnology (PBYI) Gross Profit (2017 - 2026)
Puma Biotechnology (PBYI) posted Gross Profit of $44.03 million for Q2 2026, up 9.7% from $40.14 million a year earlier and up 28.0% from the prior quarter.
Puma Biotechnology (PBYI) Gross Profit (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at Puma Biotechnology was $173.05 million, up 0.5% year-over-year; for FY2025, it was $170.21 million, up 2.5% from FY2024.
- Annual Gross Profit shows a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- In prior years, Puma Biotechnology's Gross Profit was $166.06 million in FY2024 (-4.0%), $172.96 million in FY2023 (unchanged), $172.94 million in FY2022 (-8.7%) and $189.45 million in FY2021 (+2.0%).
- Quarterly Gross Profit has run from a low of $33.04 million in Q1 2024 to a high of $52.33 million in Q4 2025 over five years.
- On a year-over-year basis, Gross Profit increased in five of the last eight quarters, with growth averaging 4.6%.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q3 2022, with growth of 24.0%; the weakest was Q1 2022, with a decline of 49.1%.
- According to Business Quant data, Gross Profit for the three prior quarters was $34.39 million (Q1 2026), $52.33 million (Q4 2025) and $42.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Puma Biotechnology | 502.85 Mn | 115.49 Mn | 44.03 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.03 Mn |
| Mar 31, 2026 | 34.39 Mn |
| Dec 31, 2025 | 52.33 Mn |
| Sep 30, 2025 | 42.30 Mn |
| Jun 30, 2025 | 40.14 Mn |
| Mar 31, 2025 | 35.45 Mn |
| Dec 31, 2024 | 45.16 Mn |
| Sep 30, 2024 | 51.45 Mn |
| Jun 30, 2024 | 36.43 Mn |
| Mar 31, 2024 | 33.04 Mn |
| Dec 31, 2023 | 47.86 Mn |
| Sep 30, 2023 | 42.83 Mn |
| Jun 30, 2023 | 42.71 Mn |
| Mar 31, 2023 | 39.56 Mn |
| Dec 31, 2022 | 48.84 Mn |
| Sep 30, 2022 | 44.61 Mn |
| Jun 30, 2022 | 44.60 Mn |
| Mar 31, 2022 | 34.89 Mn |
| Dec 31, 2021 | 43.46 Mn |
| Sep 30, 2021 | 35.97 Mn |
Puma Biotechnology Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=PBYI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();